Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 1, 2010, Pages 17-19

  Stejskal, D ^a,b   Karpisek M ^c   Svestak M ^a   Hejduk, P ^a   Sporova L ^a   Kotolova H ^c  

^a Central Moravian Hospital County   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Metabolic syndrome; PEDF

Indexed keywords

BIOLOGICAL MARKER; PIGMENT EPITHELIUM DERIVED FACTOR;

AGED; ARTICLE; CAUCASIAN; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 75749105438     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20360     Document Type: Article

References (6)

1. Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor (PEDF) in the metabolic syndrome. J Clin Endocrin Metab 2006;91:2447-2450.
2. Yamagishi S, Nakamura K, Matsui T, et al. Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor (VEGF) expression. J Biol Chem 2006;281:20213-20220.
3. Wang JJ, Zhang SX, Mott R, et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy. Evidence for antifibrogenic activities. Diabetes 2006;55:1678-1685.
4. Chen H, Jia W, Xu X, et al. Upregulation of PEDF expression by PARP inhibition contributes to the decrease in hyperglycemia-induced apoptosis in HUVECs. Biochem Biophys Res Commun 2008;369:718-724.
5. Matsuzawa Y. Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3:35-42.
6. Wang P, Smit E, Brouwers M, et al. Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot. Eur J Endocrinol 2008;59:713-718.